SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Buell Jennifer

(Last)

(First)

(Middle)

3 FORBES ROAD

(Street)

LEXINGTON

02421

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
06/11/2024

3. Issuer Name and Ticker or Trading Symbol
AGENUS INC [ AGEN ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chairman Executive Council

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	13,670	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option, right to buy	05/12/2015	02/12/2025	Common Stock	1,225	$100.8	D
Stock Option, right to buy	02/12/2015	02/12/2025	Common Stock	525	$100.8	D
Stock Option, right to buy	03/31/2017	03/31/2026	Common Stock	5,000	$83.2	D
Stock Option, right to buy	03/31/2018	03/31/2027	Common Stock	6,250	$75.4	D
Stock Option, right to buy	11/07/2018	11/07/2028	Common Stock	6,500	$41.4	D
Stock Option, right to buy	06/19/2019	06/19/2029	Common Stock	15,000	$47.6	D
Stock Option, right to buy	12/24/2019	12/24/2029	Common Stock	24,999	$82.4	D
Stock Option, right to buy	06/15/2020	06/15/2030	Common Stock	500	$72.2	D
Stock Option, right to buy	12/17/2020	12/17/2030	Common Stock	44,999	$74	D
Stock Option, right to buy	06/16/2021⁽¹⁾	01/01/2031	Common Stock	45,000	$63.6	D
Stock Option, right to buy	01/02/2022⁽²⁾	01/02/2032	Common Stock	7,500	$64.4	D
Stock Option, right to buy	01/09/2023⁽³⁾	01/09/2033	Common Stock	37,500	$47.4	D
Stock Option, right to buy	06/11/2024⁽⁴⁾	01/17/2034	Common Stock	37,500	$11.8	D

Explanation of Responses:

1. Options awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan (as amended) and vests over four years with one third vesting on the 2-year anniversary of the grant date (January 1, 2021) and the balance in equal quarterly installments thereafter.

2. Options awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan (as amended) and vests over three years with one third vesting on the one year anniversary of the grant date (January 1, 2022) and the balance in equal quarterly installments thereafter.

3. Options awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan (as amended) and vests over three years with one third vesting on the one year anniversary of the grant date (January 9, 2023) and the balance in equal quarterly installments thereafter.

4. Options were granted on January 17, 2024 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 11, 2024. Option awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan, and vests over three years with one-third of the award vesting on January 16, 2025 and the balance vesting in equal quarterly installments thereafter. The Stock Options were granted prior to the 1 for 20 reverse stock split, representing 750,000 Stock Options with an exercise price of $0.59..

	Christine M. Klaskin, by Power of Attorney	06/18/2024
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.